NFKBIA

Information NFKBIA

Description

This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]

Full Name

NFKB inhibitor alpha

Source NCBI

ReMap Statistics

Datasets
1
Biotypes
1
Peaks
1,787
Non-redundant peaks
1,787

TF Classification

Super Class
Immunoglobulin fold
Class
Rel homology region (RHR) factors
Familly
Ankyrin domain-only factors
Sub Familly
IkappaB-related factors

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000100906
UniProt
P25963
Genevisible
P25963
RefSeq
NM_020529
Aliases
EDAID2; IKBA; IkappaBalpha; MAD-3; NFKBI
All peaks NFKBIA
Download BED file
Non redundant peaks NFKBIA
Download BED file
SEQUENCES NFKBIA
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for NFKBIA

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
NFKBIA dermal GEO Homo sapiens GSE30082 1,787
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.